Bitemporal electroconvulsive therapy for depression in a parkinson disease patient with a deep-brain stimulator

Journal of ECT

Volumn 24, Issue 2, 2008, Pages 171-172

  Bailine, Samuel ^a,b   Kremen, Neil ^a,b   Kohen, Izchak ^a   Linder, Howard ^a   Schwartz, Guy J ^b,c   Mogilner, Alon Y ^c   Pourfar, Michael ^c  

^a ZUCKER HILLSIDE HOSPITAL   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c NORTH SHORE UNIVERSITY HOSPITAL   (United States)

Author keywords

Deep brain stimulator; Parkinson disease

Indexed keywords

CARBIDOPA; CLOZAPINE; ENTACAPONE; ESCITALOPRAM; LEVODOPA; LORAZEPAM; QUETIAPINE; SERTRALINE; VENLAFAXINE;

AGED; ANAMNESIS; ANXIETY DISORDER; ARTICLE; BRAIN DEPTH STIMULATION; CASE REPORT; CLINICAL FEATURE; CONTROLLED STUDY; DEPRESSION; DRUG DOSE TITRATION; DRUG RELEASE; ELECTROCONVULSIVE THERAPY; FEMALE; HUMAN; PARKINSON DISEASE; PHYSICAL EXAMINATION; PRESCRIPTION; INSTRUMENTATION; METHODOLOGY;

AGED; DEEP BRAIN STIMULATION; DEPRESSION; ELECTROCONVULSIVE THERAPY; FEMALE; HUMANS; PARKINSON DISEASE;

EID: 54049129760     PISSN: 10950680     EISSN: 15334112     Source Type: Journal    
DOI: 10.1097/YCT.0b013e318154b993     Document Type: Article

References (13)

1. Krack P, Limousin P, Benabid AL, et al. Chronic stimulation of subthalamic nucleus improves levodopa-induced dyskinesias in Parkinson's disease. Lancet. 1997;350(9092):1676.
2. Bejjani BP, Damier P, Arnulf I, et al. Transient acute depression induced by high-frequency deep-brain stimulation. N Engl J Med. 1999;340(19):1476-1480.
3. Berney A, Vingerhoets F, Perrin A, et al. Effect on mood of subthalamic DBS for Parkinson's disease: a consecutive series of 24 patients. Neurology. 2002;59(9):1427-1429.
4. Houeto JL, Mesnage V, Mallet L, et al. Behavioral disorders, Parkinson's disease, and subthalamic stimulation. J Neurol Neurosurg Psychiatry. 2002;72(6):701-707.
5. Doshi PK, Chhaya N, Bhatt MH. Depression leading to attempted suicide after bilateral subthalamic nucleus stimulation for Parkinson's disease. Mov Disord. 2002;17(5):1084-1085.
6. Thobois S, Mertens P, Guenot M, et al. Subthalamic nucleus stimulation in Parkinson's disease: clinical evaluation of 18 patients. J Neurol. 2002;249(5):529-534.
7. Rodriguez-Oroz M, Obeso J, Lang A, et al. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up. Brain. 2005;128(5):2240-2249.
8. Stern MB. Electroconvulsive therapy in untreated Parkinson's disease. Mov Disord. 1991;6(3):265.
9. Moscarillo FM, Annunziata CM. ECT in a patient with a deep brain-stimulating electrode in place. J ECT. 2000;16(3):287-290.
10. Chou KL, Hurtig HI, Jaggi JL, et al. Electroconvulsive therapy for depression in a Parkinson's disease patient with bilateral subthalamic nucleus deep brain stimulators. Parkinsonism Relat Disord. 2005;11:403-406.
11. Abrams R. Electroconvulsive Therapy. 4th ed. New York: Oxford University Press; 2002.
12. Medtronic Activa® Therapy: Important Safety Information. Available at: http://www.medtronic.com/physician/activa/disclosure.html. Accessed June 15, 2007.
13. Yamamoto T, Katayama Y, Fukaya C, et al. Thalamotomy caused by cardioversion in a patient treated with deep brain stimulation. Stereotact Func Neurosurg. 2000;74(2):73-82.